# New Blog on Combo of AG019 and Teplizumab

**URL:** https://forum.fudiabetes.org/t/new-blog-on-combo-of-ag019-and-teplizumab/8738
**Category:** T1 Research
**Created:** [November 23, 2019, 4:07pm UTC](https://forum.fudiabetes.org/t/new-blog-on-combo-of-ag019-and-teplizumab/8738 "2019-11-23T16:07:40Z")
**Posts on this page:** 1
**Page:** 1

<div class="post-metadata">

### Author: ![joshualevy](https://yyz2.discourse-cdn.com/flex030/user_avatar/forum.fudiabetes.org/joshualevy/32/2189_2.png) [@joshualevy](https://forum.fudiabetes.org/u/joshualevy)
#### Post date: [November 23, 2019, 4:07pm UTC](https://forum.fudiabetes.org/t/new-blog-on-combo-of-ag019-and-teplizumab/8738/1 "2019-11-23T16:07:40Z")

</div>

Blog posting on a clinical trial which has been going on for a while, but which I have not blogged about before:

> **[Combo of AG019 and Teplizumab Starts A Phase-I Trial In Honeymooners](https://cureresearch4type1diabetes.blogspot.com/2019/11/combo-of-ag019-and-teplizumab-starts.html)**
>
> This is another clinical trial using Teplizumab, but since this trial is more focused on AG019, I've put in a separate blog post from the ot...

AG019 is a pill containing an engineered micro-organism (Lactococcus lactis, often shortened to “L. lactis”) which generates Proinsulin and Interleukin-10 (IL-10). People in the study will take 2-6 pills once a day. So there is a lot to consider: